# Tetravalent Chimeric Dengue Vaccine Trial

> **NCT01110551** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 72 (actual)

## Conditions studied

- Dengue

## Interventions

- **DRUG:** Placebo (SC)
- **DRUG:** Placebo (ID)
- **BIOLOGICAL:** Modified Live Tetravalent Chimeric Dengue Vaccine (SC)
- **BIOLOGICAL:** Modified Live Tetravalent Chimeric Dengue Vaccine (ID)

## Key facts

- **NCT ID:** NCT01110551
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-04
- **Final completion:** 2012-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2013-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01110551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01110551, "Tetravalent Chimeric Dengue Vaccine Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01110551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*